Skip to main content
TipRanks
Go Ultimate75% OFF

AnteoTech Ltd (ADO) AI Stock Analysis

18 Followers
AU:ADO

AnteoTech Ltd

(ASX:ADO)

Select Model
Rating:38Underperform
Price Target:AUD 0.02â–¼(-5.88% Downside)
Action:downgraded
Date:10/09/26

The overall score is very low, driven primarily by a precarious financial position. The company is pre-revenue with a vanishing top line and persistent cash burn, making it entirely dependent on external funding. Technical trends are bearish, with the stock trading below key moving averages, and the negative P/E ratio confirms a lack of current earnings. The recently strengthened balance sheet provides a temporary lifeline but does not offset the fundamental operational risks.

Positive Factors
Moderate LeverageModerate leverage gives AnteoTech some balance-sheet flexibility while it develops and commercialises its diagnostics and energy-storage technologies. Lower debt exposure can reduce financing pressure and preserve room for future investment, although current losses limit the practical benefit.
Negative Factors
Sharp Revenue DeclineA sharp fall in already small and volatile revenue weakens the foundation for scaling AnteoTech's technology platforms across diagnostics and energy storage. Lower sales can reduce operating leverage, constrain investment capacity, and make a durable recovery in profitability more difficult.

AnteoTech Ltd (ADO) vs. iShares MSCI Australia ETF (EWA)

-50%0%50%100%150%AU:ADO-5.56%EWA+14.75%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
AUD 55.55M
Dividend Yield
―
Average Volume (3M)
4.25M
Price to Earnings (P/E)
-11.4
Beta (1Y)
1.87
Revenue Growth
-51.74%
EPS Growth
24.00%
Country
Australia
Employees
224
Sector
Basic Materials
Sector Strength
61
Industry
Chemicals - Specialty

AnteoTech Ltd Business Overview & Revenue Model

Company Description

AnteoTech Limited develops, manufactures, commercializes, and distributes products for clean energy technology and life science markets primarily in Australia, Asia, Europe, and North America. The company’s products include AnteoBind, a metal-ion com...

AnteoTech Ltd Financial Statement Overview

Summary

Financial performance is critically weak. The income statement shows a pre-revenue company with sales collapsing to near zero and persistent operating losses. Cash flow is negative, with the company burning cash from operations. The balance sheet is the only relative bright spot, having been fortified with equity, but this is a temporary cushion against unsustainable losses.

Income Statement

18Very Negative

Balance Sheet

55Neutral

Cash Flow

25Negative
Financial statement breakdown
BreakdownTTMJun 2026Jun 2025Jun 2024Jun 2023Jun 2022
Income Statement
Total Revenue467.59K467.59K968.88K460.40K365.72K760.88K
Gross Profit-657.22K-657.22K968.88K460.40K365.72K760.88K
EBITDA-6.91M-6.82M-7.96M-11.57M-12.35M-12.07M
Net Income-5.38M-5.38M-6.76M-8.88M-12.65M-10.72M
Balance Sheet
Total Assets15.40M15.40M6.45M9.38M5.36M15.26M
Cash, Cash Equivalents and Short-Term Investments11.20M11.20M2.34M5.03M2.72M10.10M
Total Debt2.15M2.15M1.96M2.31M1.31M1.03M
Total Liabilities3.60M3.60M3.30M4.08M2.99M2.91M
Stockholders Equity11.80M11.80M3.15M5.31M2.38M12.36M
Cash Flow
Free Cash Flow-3.58M-3.58M-6.05M-7.58M-8.77M-11.77M
Operating Cash Flow-3.53M-3.53M-5.83M-6.52M-8.08M-8.65M
Investing Cash Flow-5.55M-5.55M-174.87K-1.06M-690.83K-3.12M
Financing Cash Flow12.45M12.45M3.32M9.89M1.39M482.29K

AnteoTech Ltd Technical Analysis

Technical Analysis SentimentPositive
Last Price0.02

Price Trends

50DMA0.02Positive
100DMA0.02Negative
200DMA0.02Positive

Market Momentum

MACD0.00Negative
RSI52.25Neutral
STOCH177.78Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:ADO, the sentiment is Positive. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bullish trend. The MACD of 0.00 indicates Negative momentum. The RSI at 52.25 is Neutral, neither overbought nor oversold. The STOCH value of 177.78 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:ADO.

AnteoTech Ltd Peers Comparison

Overall Rating

UnderperformOutperform
Sector (61)

Financial Indicators

AU:ADO against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
Sector *61Neutral$10.43B7.12-0.05%2.87%2.86%-36.73%
AU:TLXAU:TLX53NeutralAUD 4.54B93.907.24%―26.66%179.32%
AU:CU6AU:CU645NeutralAUD 705.12M-6.52-51.15%――-44.83%
AU:SPLAU:SPL43NeutralAUD 200.41M-24.27-42.35%―145.32%25.75%
AU:RADAU:RAD42NeutralAUD 14.13M-0.19-144.24%―-23.82%12.36%
AU:PIQAU:PIQ38UnderperformAUD 15.88M-1.65-129.15%―-23.71%-16.02%
AU:ADOAU:ADO38UnderperformAUD 52.28M-11.43-77.75%―-51.74%24.00%

* Basic Materials Sector Average

Performance Comparison

-50%0%50%100%150%AU:ADOAU:SPLAU:TLXAU:CU6AU:PIQAU:RADDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
AU:ADO and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
AU:ADOAnteoTech Ltd0.02-0.00-10.53%
AU:SPLStarpharma Holdings Limited0.420.036.52%
AU:TLXTelix Pharmaceuticals Ltd.13.21-0.67-4.83%
AU:CU6Clarity Pharmaceuticals Ltd.1.83-1.90-50.94%
AU:PIQProteomics International Laboratories Ltd.0.09-0.23-70.63%
AU:RADRadiopharm Theranostics Limited0.01-0.01-52.38%

AnteoTech Ltd Corporate Events

AnteoTech Reports Cessation of Five Million Options

Nov 16, 2026

AnteoTech Ltd reported that 5 million ADOAAA options ceased on November 14, 2026, because the conditions attached to the conditional right to securities were not met or became incapable of being satisfied. The options were identified as expiring on t...

AnteoTech Applies to Quote 2,292,854 Ordinary Securities

Nov 11, 2026

AnteoTech Ltd is identified as an ASX issuer under code ADO. The release provides no information on its industry, primary products, services or market focus.AnteoTech applied for quotation of 2,292,854 ADO ordinary fully paid securities, with an issu...

AnteoTech Reports All Resolutions Passed at 2026 AGM

Nov 10, 2026

AnteoTech reported that all resolutions at its 10 November 2026 annual general meeting were passed by poll. The resolutions covered the remuneration report, the re-election of non-executive director Dr Geoff Cumming, long-term incentive options for M...

AnteoTech 2026 AGM MD/CEO Presentation

Nov 9, 2026

AnteoTech Ltd (ASX: ADO) is identified in the presentation as the company, but the supplied text does not specify its industry, primary products or market focus. The 10 November 2026 MD/CEO presentation is associated with the company’s annual general...

AnteoTech reports FY2026 portfolio expansion and lower revenue

Nov 9, 2026

AnteoTech said FY2026 was the first full year of its portfolio-based strategy, which broadened its focus beyond the European electric-vehicle market to end-use applications across several jurisdictions. It launched three battery products, expanded An...

AnteoTech advances battery and diagnostics commercialisation, boosts cash with R&D rebate

Oct 28, 2026

AnteoTech’s September quarter was dominated by commercial execution, with expanded customer validations for its battery additives and Ultranode cells across Asia and the U.S. The company advanced negotiations on Ultranode 95 joint development deals,...

AnteoTech appoints veteran finance executive as new CFO and Company Secretary

Oct 27, 2026

AnteoTech Ltd has announced the appointment of Luke Oxenham as Chief Financial Officer and Company Secretary, effective 23 November 2026, following the resignation of former CFO and Company Secretary Scott Waddell earlier in the year. Oxenham, who wi...

AnteoTech outlines AnteoBind market opportunities in ASX investor update

Oct 21, 2026

AnteoTech has released an investor presentation outlining market opportunities and partnership prospects for its AnteoBind technology within its life sciences business. The document, approved for ASX release, is framed as an update on operations and...

AnteoTech Showcases Ultra-Thin, Safer Lithium-Ion Battery Separator Additives

Oct 13, 2026

AnteoTech Ltd used its presentation at The Battery Show North America in Detroit to highlight new structural performance additives designed to break the 10 µm thickness barrier in lithium-ion battery separators. By combining exceptional thermal safet...

AnteoTech sets in-person 2026 AGM as it sharpens investor engagement

Oct 6, 2026

AnteoTech Ltd has released its 2026 Notice of Annual General Meeting, confirming the AGM will be held in person on 10 November 2026 at Rydge’s South Bank in Brisbane, with a live broadcast available for viewing but without online participation. The c...

AnteoTech Publishes FY2026 Results and Schedules Investor Webinar

Sep 29, 2026

AnteoTech Ltd has released its full-year 2026 results and a business update presentation, which will be discussed in a live webinar hosted by Managing Director and CEO Merrill Gray. The session, scheduled for 30 September 2026, will be accessible via...

AnteoTech boosts cash reserves with $1.9m R&D tax rebate

Sep 29, 2026

AnteoTech Ltd has received a $1.9 million Research and Development Tax Incentive rebate from the Australian Taxation Office for the 2026 financial year. The rebate relates to eligible Australian R&D activities across its Advanced Battery Technologies...

AnteoTech refreshes governance framework and diversity disclosures

Sep 27, 2026

AnteoTech has updated its corporate governance statement, reaffirming its alignment with the ASX Corporate Governance Council’s fourth edition principles and its adoption of a revised Corporate Governance Charter first implemented in late 2020. The b...

AnteoTech Issues New Tranche of Unquoted Employee Options

Sep 24, 2026

AnteoTech Ltd has disclosed the issuance of 8,758,000 unquoted options under its employee incentive scheme, with an exercise price of $0.0375 and an expiry date of 22 September 2030. The options, not intended to be quoted on the ASX, represent a cont...

AnteoTech schedules FY26 investor briefing to outline growth plans

Sep 22, 2026

AnteoTech Ltd will host an investor webinar and conference call on 30 September 2026 to discuss its FY26 results, which are scheduled for release on 28 September 2026. Managing director and CEO Merrill Gray will brief investors on the company’s FY202...

AnteoTech Sets November Date for 2026 Annual General Meeting

Sep 17, 2026

AnteoTech Ltd has scheduled its 2026 Annual General Meeting for 10:00 a.m. AEST on 10 November 2026 at Rydges South Bank in Brisbane, with director nominations closing on 25 September and detailed AGM materials to be released to the market by 9 Octob...

AnteoTech Issues Equity Incentive Shares Under Corporations Act Cleansing Notice

Sep 15, 2026

AnteoTech has issued 5,386,569 fully paid ordinary shares to staff as part of its FY2026 performance outcomes under the company’s Equity Incentive Plan. The shares were issued without a disclosure document under the provisions of section 708A of the...

AnteoTech lifts FY2026 loss after non-cash lease adjustment

Sep 15, 2026

AnteoTech Ltd, an ASX-listed technology company based in Brisbane, focuses on advanced materials and diagnostics solutions for commercial and industrial markets, with investors closely tracking its capital position and adherence to financial reportin...

AnteoTech Options Lapse, Streamlining Capital Structure

Sep 13, 2026

AnteoTech Ltd has notified the ASX of the cessation of 73,251,921 options, ADOAY, which expired on Sept. 13, 2026, without being exercised or converted. The lapse of these options reduces the pool of potential future share dilution, clarifying the co...

AnteoTech CFO and Company Secretary Steps Down, Succession Process Begins

Sep 8, 2026

AnteoTech Limited has announced the resignation of Chief Financial Officer and Company Secretary Scott Waddell, who is leaving to pursue other business interests. The board has thanked Waddell for his contribution and will commence a search process t...

AnteoTech Issues Shares Under Short-Term Incentive Plan After KPI Review

Sep 1, 2026

AnteoTech has completed its FY2026 annual staff and executive performance review, concluding that 70.9% of company-wide KPIs were achieved in line with its ongoing commercialisation strategy. In recognition, the board approved the issuance of approxi...

AnteoTech plans equity placement of 5.5 million new shares

Sep 1, 2026

AnteoTech Ltd has notified the Australian Securities Exchange of a proposed placement involving up to 5,544,884 ordinary fully paid shares. The company expects to issue the new securities on 15 September 2026, subject to ASX processes and listing rul...

AnteoTech Narrows Loss as Cost Cuts and Fresh Capital Strengthen Balance Sheet

Aug 31, 2026

AnteoTech Ltd reported a narrower full-year loss of $4.93 million for the year to 30 June 2026, down 27% from the prior year, as cost reductions offset weaker operating revenue. Revenue from ordinary activities fell 52% to $0.47 million, though total...

AnteoTech Refreshes Securities Trading Policy to Bolster Governance

Aug 26, 2026

AnteoTech Limited has updated its Securities Trading Policy, effective 26 August 2026, signalling a refresh of its governance framework around share dealing by insiders. The revised policy, released to the market and made available on the company’s w...

AnteoTech triples life sciences sales pipeline after ADLM 2026

Aug 24, 2026

AnteoTech reported a significant expansion of its Life Sciences sales pipeline following its attendance at the ADLM 2026 diagnostics and laboratory medicine conference in Anaheim. The company engaged with diagnostic test and particle manufacturers, p...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 09, 2026